Proteomics: Technologies and Global Markets

Jan 2023| BIO034F| BCC Publishing
Sample Report

Report Highlights

The global proteomics market should reach $55.1 billion by 2027 from $27.1 billion in 2022 at a compound annual growth rate (CAGR) of 15.3% for the forecast period of 2022 to 2027.

Report Includes

  • 149 data tables and 97 additional tables
  • An up-to-date overview of the global markets for proteomics and related technologies
  • Analyses of the global market trends, with historic market revenue data from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of the upcoming market potential for the global proteomics industry, growth driving factors, and areas of focus to forecast this market into various segments and sub-segments
  • Estimation of the actual market size and market forecast for proteomics in value (USD millions) terms, and their corresponding market share analysis by platform technology, end-user application, and region
  • In-depth information (facts and figures) concerning major market dynamics (DROs), technology advancements, new products and applications in proteomics, and COVID-19 impact on the market for proteomics
  • Insight into recent industry structure for proteomics technologies, competitive aspects of each product segments, major growth strategies, and company value share analysis based on their segmental revenues
  • Updated information on key mergers and acquisition deals, agreements, partnerships, collaborations and product launches within the global proteomics industry
  • Profile descriptions of the leading proteomics manufacturers, including Agilent, Danaher Corp., GlaxoSmithKline PLC, PerkinElmer Inc., Qiagen GmbH, and Sanofi.

Report Scope

The study’s scope covers MS instruments, consumables, workflow products, planar arrays, bead arrays, and LOACs. It also covers the research, drug discovery and development, diagnostics, and applied end-user market segments. The main geographical markets—North America, Europe, Asia-Pacific, and Rest of the World (ROW)—are included.

The MS market is covered by instrument type, MS consumables, and product type and end-user markets. The biochip market is covered by biochip type and the end-user market for each type. The diagnostics market is covered in some detail, including by major platform (i.e., MS, biochips), by disease type and for cancer by indication. This report provides the current market sizes for these segments, as well as their forecasted growth to 2027.

Technology status and forces driving the market are discussed and analyzed. Factors that influence each market are also highlighted, including growth-driving forces, industry alliances and acquisitions, applications in diagnostics and drug discovery, customer needs, and competitive trends.

Key industry acquisitions and strategic alliances are given for the five-year period from 2021 through 2027.

This report examines the main patent trends within the industry and profiles proteomics companies.

Frequently Asked Questions (FAQs)

The proteomics market is projected to grow from $23.5 billion in 2021 to $55.1 billion in 2027, at a compound annual growth rate (CAGR) of 15.3% during the forecast period.
The key factors driving the growth of Proteomics market includes Growth in genomics-based discovery, Vibrant industry deal-making, Increasing government and private funding, and Continuing development of novel platforms.
The Proteomics market is segmented based on platform type, end-user, and region.
Mass spectrometers (MS) segment will dominate the market by the end of 2027.
North America holds the highest share in the market.
Key companies in the market include • Agilent Technologies Inc. • Biognosys AG • Bio-Rad Laboratories Inc. • Bruker Corporation • Danaher Corporation • GE Healthcare • HORIBA Ltd. • Illumina, Inc. • Merck KGaA. • PerkinElmer Inc. • Promega Corp. • Thermo Fisher Scientific Inc. • Waters Corporation.

Analyst Credentials

BCC Publishing Staff comprises expert analysts who are skilled in conducting primary research, secondary research and data analysis and have decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies. Collectively, the team represents a diverse set of educational achievements with individual graduate work completed in fields such as microbiology, electrical engineering, business administration and surgery, among others.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022 to 2027
Base year market size $23.5 billion
Market size forecast $55.1 billion
Growth rate CAGR of 15.3% for the forecast period of 2022-2027
Units considered $ Millions
Segments covered Platform, Type, End User, Indication, and Technique
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (ROW)
Countries covered U.S., Canada, U.K., Germany, France, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Australia, Rest of Asia-Pacific, and Rest of the World
Key Market Drivers
  • Innovation and Automation
  • Demand for High-Quality Samples
  • Automation Leading to Better Results
  • Personal Genomics Market-Booming Niche
  • Cost of Equipment
  • High Cost of Complex Sample Preparation
  • Wide Application of Genomics
  • Increasing Demand for Proteomics
  • Data Privacy a Major Concern
Companies studied
ABCODIA LTD.
ACTIVX BIOSCIENCES INC.
ADVANCED PROTEOME THERAPEUTICS INC.
AGILENT TECHNOLOGIES INC.
APPLIED PROTEOMICS
ARRAYIT CORP.
ASTUTE MEDICAL INC.
AVACTA LIFE SCIENCES LTD.
AYOXXA BIOSYSTEMS GMBH
BECTON, DICKINSON AND CO.
BIOCARTIS NV
BIODESIX INC.
BIOGNOSYS AG
BIOMERIEUX SA
BIO-RAD LABORATORIES INC.
BIO-TECHNE INC.
BRUKER CORP.
CAMBRIDGE PROTEIN ARRAYS LTD.
CHARLES RIVER LABORATORIES INTERNATIONAL INC.
CRYSTALGENOMICS INC.
DANAHER CORP.
EPICYPHER INC.
EVOTEC AG
GENERAL ELECTRIC CO.
GLAXOSMITHKLINE PLC
GL SCIENCES INC.
ILLUMINA INC.
IMMUNOVIA AB
IMTAKT CORP.
INTEGRATED DIAGNOSTICS HOLDING
INDI MOLECULAR
LABCYTE INC.
LIMINAL BIOSCIENCES INC.
MERCK & CO. INC.
MERCK KGAA
MRM PROTEOMICS INC.
MYCARTIS
MYRIAD GENETICS INC.
NEWOMICS INC.
NIRMIDAS BIOTECH INC.
OLINK BIOSCIENCE
OPKO HEALTH INC.
PERKINELMER INC.
PERSONALIZED CANCER THERAPY INC.
PFIZER INC.
PHENOMENEX INC.
PRESSURE BIOSCIENCES INC.
PROTAGEN AG
PROTEA BIOSCIENCES INC.
PROTEOCYTE DIAGNOSTICS INC.
PROTEOGENIX
PROTEOME SCIENCES PLC
PROTEOMICS INTERNATIONAL PTY LTD.
PYC THERAPEUTICS. (FORMERLY PHYLOGICA LTD.)
QIAGEN N.V.
QUANSYS BIOSCIENCES
QUANTERIX INC.
QUEST DIAGNOSTICS INC.
REPLIGEN CORP.
ROCHE (F. HOFFMANN-LA ROCHE LTD.)
SAMDI TECH INC.
SANOFI
SERA PROGNOSTICS
SHIMADZU CORP.
SHISEIDO COMPANY LTD.
SHOWA DENKO KK
SINGULEX INC.
SISCAPA ASSAY TECHNOLOGIES INC.
SOMALOGIC INC.
SPOTON CLINICAL DIAGNOSTICS LTD.
SQI DIAGNOSTICS
STANDARD BIOTOOLS INC. (FORMERLY FLUIDIGM)
SYNAGEVA BIOPHARMA (ACQUIRED BY ALEXION PHARMACEUTICALS INC.)
T2 BIOSYSTEMS
THERMO FISHER SCIENTIFIC INC.
THORNE DIAGNOSTICS INC.
TOSOH CORP.
TRAJAN SCIENTIFIC AND MEDICAL
UNIVERSAL BIOSENSORS LTD.
VG LIFE SCIENCES INC.
WATERS CORP.
XENCOR INC.
YMC CO. LTD.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesPrice Member Price
Full Report: Proteomics: Technologies and Global Markets384 $5,500 Free
Chapter- 1: Introduction10Free DownloadFree
Chapter- 2: Summary and Highlights5$250Free
Chapter- 3: Overview10$143Free
Chapter- 4: COVID 19 Impact on Proteomics Market5$72Free
Chapter- 5: Proteomics Technologies14$201Free
Chapter- 6: Proteomics Applications in Drug Discovery and Development4$57Free
Chapter- 7: Proteomics Scientific Initiatives3$43Free
Chapter- 8: Clinical Proteomics Applications40$573Free
Chapter- 9: Proteomics Industry33$473Free
Chapter- 10: Proteomics Markets31$444Free
Chapter- 11: Proteomics Market by Geographic Segmentation59$845Free
Chapter- 12: Proteomics Patents43$616Free
Chapter- 13: Competitive Landscape17$243Free
Chapter- 14: Company Profiles110$1,576Free
Published - Oct-2018| Analyst - Bhavna Joshi| Code - BIO034E

Report Highlights

The global market for proteomics should grow from $7.9 billion in 2017 to $16.8 billion by 2022 at a compound annual growth rate (CAGR) of 16.2% for the period of 2017-2022.

Report Includes

  • 20 data tables and 62 additional tables
  • An overview of the global proteomics market, which covers: technologies, platform and software markets, disease markets, biochip markets and end-use industry markets
  • Analyses of global market trends, with data from 2016 and 2017, and projections of CAGRs through 2022
  • Examination of market trends and opportunities that will impact the future market
  • A look at proteomics scientific initiatives, industry acquisitions and patents
  • Discussion of proteomic applications in drug discovery and development
  • Comprehensive company profiles across subsegments, such as protein chip providers, reagent providers, service providers, informatics and database providers, etc.
  • Company profiles of major players, including Abcodia Ltd., Bruker Corp., Digilab Inc., Glaxosmithkline Plc., & Luminex Corp.
Published - Feb-2015| Analyst - John Bergin| Code - BIO034D

Report Highlights

The global proteomics market was valued at nearly $5.1 billion in 2014 and is growing at a compound annual growth rate (CAGR) of 18.0% to reach a forecast value of $11.6 billion by 2019.

Report Includes

  • An overview of the global proteomics market, which covers: technologies, database and software markets, equipment markets, application markets and service markets.
  • Analyses of global market trends, with data from 2013 and 2014, and projections of CAGRs through 2019.
  • Discussion of trends and opportunities, top-selling products, key players, and a competitive outlook.
  • Comprehensive company profiles across subsegments, such as protein chip providers, reagent providers, service providers, informatics and database providers, etc.
Published - May-2013| Analyst - John Bergin| Code - BIO034C

Report Highlights

The global proteomic market was worth nearly $3.7 billion in 2011 and nearly $4.2 billion in 2012, and is forecast to grow at a compound annual growth rate (CAGR) of 16.1% during the next five years to reach nearly $8.9 billion in 2017.

Report Includes

  • An overview of the global proteomics market, which covers: technologies, database and software markets, equipment markets, application markets and service markets.
  • Analyses of global market trends, with data from 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017.
  • Discussion of trends and opportunities, top-selling products, key players, and a competitive outlook.
  • Comprehensive company profiles across subsegments, such as protein chip providers, reagent providers, service providers, informatics and database providers, etc.
Published - Jun-2009| Analyst - Sathya Durga| Code - BIO034B

Report Highlights

  • The global market for proteomics is expected to increase from $6.7 billion in 2008 to an estimated $7.9 billion in 2009 and $19.4 billion in 2014, for a compound annual growth rate (CAGR) of 19.7%.
  • Proteomics equipment was valued at $4.1 billion in 2008 and an estimated $4.8 billion in 2009. This is expected to increase to $13.0 billion in 2014, for a CAGR of 22%..
  • Proteomics technologies were worth $1.3 billion in 2008 and an estimated $1.5 billion in 2009. This segment is expected to increase at a CAGR of 13.9% to reach $2.9 billion in 2014.
Published - Jan-2002| Analyst - Valarie Natale| Code - BIO034A

Report Highlights

  • Proteomics is an emerging field that has developed in the wake of genomics. Its goal is to understand protein expression at the cellular level, and apply this information to scientific and medical problems. For example, compared to healthy cells, how does influenza virus infection affect the total protein output? Are any of the proteins expressed only in the infected cells suitable targets for new antiviral drugs? This approach also applies to cancerous cells, and cells from patients with degenerative diseases and many other conditions. New technologies like protein chips and capillary electrophoresis are emerging to serve proteomic studies, and more mature technologies like 2-D electrophoresis, mass spectroscopy, and nuclear magnetic resonance spectroscopy are being adapted for protein studies, and in some cases, for high throughput uses. Bioinformatics applications are constantly being developed to analyze the data produced by all of these technologies.
  • This BCC study examines how proteomics technologies have affected basic research and pharmaceutical research, and how they are likely to affect research in the near future. It also analyzes how proteomics technologies are developing, and examines new companies that are likely to make substantial contributions to the field. An important part of the report analyzes instruments that are vital to proteomics studies. Sales and spending projections through 2006 are included.

Proteomics: Technologies and Global Markets

Single User License: $5500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS